Literature DB >> 33385685

3D culture of HepaRG cells in GelMa and its application to bioprinting of a multicellular hepatic model.

Marie Cuvellier1, Frédéric Ezan2, Hugo Oliveira3, Sophie Rose2, Jean-Christophe Fricain4, Sophie Langouët2, Vincent Legagneux2, Georges Baffet5.   

Abstract

Bioprinting is an emergent technology that has already demonstrated the capacity to create complex and/or vascularized multicellular structures with defined and organized architectures, in a reproducible and high throughput way. Here, we present the implementation of a complex liver model by the development of a three-dimensional extrusion bioprinting process, including parameters for matrix polymerization of methacrylated gelatin, using two hepatic cell lines, Huh7 and HepaRG. The printed structures exhibited long-term viability (28 days), proliferative ability, a relevant hepatocyte phenotype and functions equivalent to or better than those of their 2D counterparts using standard DMSO treatment. This work served as a basis for the bioprinting of complex multicellular models associating the hepatic parenchymal cells, HepaRG, with stellate cells (LX-2) and endothelial cells (HUVECs), able of colonizing the surface of the structure and thus recreating a pseudo endothelial barrier. When bioprinted in 3D monocultures, LX-2 expression was modulated by TGFβ-1 toward the induction of myofibroblastic genes such as ACTA2 and COL1A1. In 3D multicellular bioprinted structures comprising HepaRG, LX-2 and endothelial cells, we evidenced fibrillar collagen deposition, which is never observed in monocultures of either HepaRG or LX-2 alone. These observations indicate that a precise control of cellular communication is required to recapitulate key steps of fibrogenesis. Bioprinted 3D co-cultures therefore open up new perspectives in studying the molecular and cellular basis of fibrosis development and provide better access to potential inducers and inhibitors of collagen expression and deposition.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  3D liver models; Bioprinting; HepaRG; Hepatocyte; Methacrylated gelatin

Mesh:

Substances:

Year:  2020        PMID: 33385685     DOI: 10.1016/j.biomaterials.2020.120611

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  7 in total

1.  DMSO-free highly differentiated HepaRG spheroids for chronic toxicity, liver functions and genotoxicity studies.

Authors:  Marie Cuvellier; Frédéric Ezan; Georges Baffet; Sophie Langouët; Sophie Rose; Jennifer Carteret; Arnaud Bruyère; Vincent Legagneux; Fabrice Nesslany
Journal:  Arch Toxicol       Date:  2021-11-11       Impact factor: 5.153

Review 2.  Handheld bioprinting strategies for in situ wound dressing.

Authors:  Hongbin Li; Feng Cheng; Dennis P Orgill; Junjie Yao; Yu Shrike Zhang
Journal:  Essays Biochem       Date:  2021-08-10       Impact factor: 7.258

Review 3.  Bioengineered Liver Cell Models of Hepatotropic Infections.

Authors:  Francisca Arez; Ana F Rodrigues; Catarina Brito; Paula M Alves
Journal:  Viruses       Date:  2021-04-27       Impact factor: 5.048

Review 4.  Bioprinting Au Natural: The Biologics of Bioinks.

Authors:  Kelsey Willson; Anthony Atala; James J Yoo
Journal:  Biomolecules       Date:  2021-10-28

5.  One-Step Generation and Purification of Cell-Encapsulated Hydrogel Microsphere With an Easily Assembled Microfluidic Device.

Authors:  Tao Zhang; Hong Zhang; Wuping Zhou; Keming Jiang; Cong Liu; Ru Wang; Yuanshuai Zhou; Zhiqiang Zhang; Qian Mei; Wen-Fei Dong; Minxuan Sun; Haiwen Li
Journal:  Front Bioeng Biotechnol       Date:  2022-01-28

6.  Development of Biomimetic Hepatic Lobule-Like Constructs on Silk-Collagen Composite Scaffolds for Liver Tissue Engineering.

Authors:  Lina Guo; Ziqing Zhu; Chuanzhou Gao; Kaiwen Chen; Shenzhou Lu; Hexin Yan; Wenming Liu; Mingqi Wang; Yanfang Ding; Lin Huang; Xiuli Wang
Journal:  Front Bioeng Biotechnol       Date:  2022-06-23

7.  Preservation of Small Extracellular Vesicle in Gelatin Methacryloyl Hydrogel Through Reduced Particles Aggregation for Therapeutic Applications.

Authors:  Kelun Wu; Chuan He; Yue Wu; Xiaojie Zhou; Pan Liu; Wei Tang; Mei Yu; Weidong Tian
Journal:  Int J Nanomedicine       Date:  2021-11-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.